Dominion Diagnostics is pleased to announce its renewed commitment to support education and advancement in addiction medicine and behavioral healthcare. For its second consecutive year, Dominion is the Series Thought Leadership Partner for the 2014 Addiction Professional Panel Series hosted by Vendome Healthcare Media.
Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, is uniting with other donors in the business community to raise funds for the victims of the Boston Marathon bombings.
Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, will sponsor a year-long series of regional educational Lunch’n’Learns hosted by Addiction Professional, a magazine published for the addiction treatment field by Vendome Healthcare Media.
Leading national drug testing and medication monitoring company Dominion Diagnostics has launched new, more sensitive, and more relevant testing to detect synthetic cathinones or “bath salts” in urine. Designed by Dominion’s Research and Development team, the test will detect five synthetic cathinones: mephedrone, 3,4-methylendioxypyrovalerone (MDPV), methylone, butylone, and ethylone. The testing, performed by liquid c
A free, one-day continuing education symposium for addiction treatment professionals, “Treatment, Intervention & Innovation: Challenges and Solutions in the Addiction Field Today”, will be held at the Mission Bay Conference Center at the University of California San Francisco at 1675 Owens Street in San Francisco on Wednesday, June 13, 2012. The program is scheduled from 8:30 a.m. to 5:00 p.m.
Dominion Diagnostics, LLC, a leading national medication and substance use monitoring company, is celebrating its fifteenth year in business providing quality monitoring services, clinical support and education to improve patient outcomes in addiction treatment and pain management.